MRI in multiple sclerosis: a review of the current literature.

PURPOSE OF REVIEW This review summarizes the recent data pertaining to the use of magnetic resonance imaging (MRI) in assessing brain and spinal cord involvement in multiple sclerosis (MS). RECENT FINDINGS Using MRI as a tool, investigators have made progress recently in understanding the substrate and mechanisms underlying the development and evolution of focal lesions and diffuse damage in MS. The application of refined MRI sequences has markedly improved the characterization of focal lesions, in particular cortical lesions. Promising improvements have been made to clarify the pathological specificity and sensitivity of MRI techniques by performing combined histopathologic-MRI correlation studies. The use of high-field (3 T) and ultra-high-field (UHF; >3 T) MRI has further facilitated the detection of both gray matter and white matter microstructural damage, and elucidated the topographic relationship of overt damage to venous blood vessels. The development of advanced MRI postprocessing tools has led to additional progress in detecting clinically relevant regional gray matter and white matter damage. SUMMARY MRI continues to play a pivotal role in the investigation of MS. Ongoing advances in MRI technology should further expand the current understanding of pathologic disease mechanisms and improve diagnostic, prognostic, and monitoring ability in patients with MS.

[1]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[2]  R Bakshi,et al.  The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis , 2012, American Journal of Neuroradiology.

[3]  Bertrand Audoin,et al.  Prevalence of Grey Matter Pathology in Early Multiple Sclerosis Assessed by Magnetization Transfer Ratio Imaging , 2011, PloS one.

[4]  F. Barkhof,et al.  Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis , 2011, Multiple sclerosis.

[5]  R. Bakshi,et al.  Approaches to Normalization of Spinal Cord Volume: Application to Multiple Sclerosis , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[6]  Massimiliano Calabrese,et al.  Modeling the Distribution of New MRI Cortical Lesions in Multiple Sclerosis Longitudinal Studies , 2011, PloS one.

[7]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[8]  Nikos Evangelou,et al.  3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions , 2010, Journal of magnetic resonance imaging : JMRI.

[9]  R Bakshi,et al.  Identification and Clinical Impact of Multiple Sclerosis Cortical Lesions as Assessed by Routine 3T MR Imaging , 2011, American Journal of Neuroradiology.

[10]  S Ropele,et al.  Determinants of brain iron in multiple sclerosis , 2011, Neurology.

[11]  Elizabeth Fisher,et al.  Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations , 2011, Annals of neurology.

[12]  M. Neema,et al.  A 3T MR Imaging Investigation of the Topography of Whole Spinal Cord Atrophy in Multiple Sclerosis , 2011, American Journal of Neuroradiology.

[13]  M. Dwyer,et al.  Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy , 2012, American Journal of Neuroradiology.

[14]  H. Brückmann,et al.  Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? , 2011, Neuroradiology.

[15]  Yong He,et al.  Diffusion tensor tractography reveals disrupted topological efficiency in white matter structural networks in multiple sclerosis. , 2011, Cerebral cortex.

[16]  M. Horsfield,et al.  A multicenter assessment of cervical cord atrophy among MS clinical phenotypes , 2011, Neurology.

[17]  Michael Montag,et al.  Corpus callosal diffusivity predicts motor impairment in relapsing–remitting multiple sclerosis: A TBSS and tractography study , 2011, NeuroImage.

[18]  P S Morgan,et al.  Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions , 2011, Neurology.

[19]  M. Filippi,et al.  Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype , 2011, Human brain mapping.

[20]  P. Morgan,et al.  Focal multiple sclerosis lesions abound in ‘normal appearing white matter’ , 2011, Multiple sclerosis.

[21]  Hsiao-Fang Liang,et al.  Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords , 2011, NeuroImage.

[22]  Robert Zivadinov,et al.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.

[23]  M. Battaglini,et al.  Cortical lesions in radiologically isolated syndrome , 2011, Neurology.

[24]  Brian K. Rutt,et al.  Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI , 2012, NeuroImage.

[25]  M. Filippi,et al.  Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. , 2011, Radiology.

[26]  Alessandra Bertoldo,et al.  Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. , 2011, Radiology.

[27]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[28]  Ludwig Kappos,et al.  Multivariate pattern classification of gray matter pathology in multiple sclerosis , 2012, NeuroImage.

[29]  M. Filippi,et al.  Voxelwise Assessment of the Regional Distribution of Damage in the Brains of Patients with Multiple Sclerosis and Fatigue , 2011, American Journal of Neuroradiology.

[30]  David H. Miller,et al.  Assessing Neuronal Metabolism In Vivo by Modeling Imaging Measures , 2010, The Journal of Neuroscience.

[31]  Robert A. Gross,et al.  Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI , 2011 .

[32]  M. Filippi,et al.  Cortical lesions in children with multiple sclerosis , 2011, Neurology.

[33]  David H. Miller,et al.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes , 2010, Journal of magnetic resonance imaging : JMRI.

[34]  M. Battaglini,et al.  T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  T. Benner,et al.  Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH‐T2* , 2012, Journal of magnetic resonance imaging : JMRI.

[36]  C. Guttmann,et al.  Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study , 2012, Journal of the Neurological Sciences.

[37]  Maria Assunta Rocca,et al.  Thalamic damage and long-term progression of disability in multiple sclerosis. , 2010, Radiology.

[38]  Daniel S Reich,et al.  Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions , 2011, Annals of neurology.

[39]  M. Battaglini,et al.  T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  M. Calabrese,et al.  The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.

[41]  M. Horsfield,et al.  Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis , 2012, Neurology.

[42]  Rohit Bakshi,et al.  MRI in multiple sclerosis: current status and future prospects , 2008, The Lancet Neurology.

[43]  Ponnada A Narayana,et al.  Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis , 2011, Multiple sclerosis.

[44]  M. Sormani,et al.  Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis , 2011, Neurology.

[45]  M. White,et al.  Cervical spinal cord multiple sclerosis: evaluation with 2D multi-echo recombined gradient echo MR imaging , 2011, The journal of spinal cord medicine.

[46]  Mara Cercignani,et al.  Corpus callosum damage predicts disability progression and cognitive dysfunction in primary‐progressive MS after five years , 2013, Human brain mapping.

[47]  Mark Jenkinson,et al.  The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis , 2012, Human brain mapping.

[48]  AJ Thompson,et al.  Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis , 2012, Multiple sclerosis.

[49]  M. Filippi,et al.  Intracortical lesions , 2010, Neurology.

[50]  Rohit Bakshi,et al.  The Relationships among MRI‐Defined Spinal Cord Involvement, Brain Involvement, and Disability in Multiple Sclerosis , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[51]  Peiqing Qian,et al.  Heterogeneity in longitudinal evolution of ring‐enhancing multiple sclerosis lesions , 2011, Annals of neurology.

[52]  P. Narayana,et al.  Composite MRI scores improve correlation with EDSS in multiple sclerosis , 2010, Multiple sclerosis.

[53]  F. Barkhof,et al.  Postmortem verification of MS cortical lesion detection with 3D DIR , 2012, Neurology.

[54]  D. Goodin,et al.  Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome , 2011, Neurology.

[55]  A. Thompson,et al.  Cervical cord and brain grey matter atrophy independently associate with long-term MS disability , 2010, Journal of Neurology, Neurosurgery & Psychiatry.